NewsNano-sized vesicles with ACE2 receptor could prevent, treat
infection from current and future strains of SARS-CoV-2

20th January 2022by admin0
https://nfusion-tech.com/wp-content/uploads/2022/01/nano-sized-vesicles-with-ace2-receptor-could-prevent-treatinfection-from-current-and-future-strains-of-sars-cov-2_61ea7fa4a039a.jpeg

Scientists at The University of Texas MD Anderson
Cancer Center and Northwestern Medicine have identified natural
extracellular vesicles containing the ACE2 protein (evACE2) in the
blood of COVID-19 patients that can block infection from broad
strains of SARS-CoV-2 virus in preclinical studies. The study was
published today in Nature Communications.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2022 New Fusion All Rights Reserved

      Designed by FallingBrick